PATENT CLAIM ANALYSIS

Application Number: 16302158
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "210180"]

Abstract:
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament.

Claim (Index 2):
The compound according to  claim 1 , wherein the compound is represented by Formula (IIa) or (IIb): wherein:\n G is N or C; \n m is 0, 1, or 2; and \n R 2  is, independently at each occurrence, selected from: halogen, C 1-4  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, and C 1-4  haloalkoxy.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.15152
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13936311', '13944921', '14427105', '14346745', '14390152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7668602130256548
- 35 USC 102 Novelty (BERT): 0.5187468458432548
- Combined Prediction Score: 0.7420488763074149
- Mean Citation Score: 302.8511640000001
- Max Citation Score: 311.87286
- Similarity Product: 274.77463234561094

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test